IPSIS Provides RFA Evidence to Arkansas Blue Cross and Blue Shield

On January 3, 2020, IPSIS offered evidence to Arkansas Blue Cross and Blue Shield in support of coverage for third occipital nerve and lateral branch radiofrequency neurotomy (RFN) and radiofrequency ablation (RFA) of the genicular nerves associated with knee osteoarthritis. The Society’s comments refute classification of these procedures as investigational and advocate for coverage in appropriately selected patients.

Members may click here 🔒 to read the IPSIS comment letter.

Given the strength and quality of the evidence in support of the safety and effectiveness of lateral branch radiofrequency RFN and genicular nerve RFA, Category I CPT codes were adopted 🔒 by the Centers for Medicare and Medicaid Services (CMS) effective January 1, 2020.